Score
2
1990
pubmed
[Administration of immunocorrective agents into the greater omentum in the complex treatment of non-circumscribed peritonitis].
Usov. S N SN; Ol'shanetskiĭ. A A AA
Key Findings
- Intramuscular thymalin had no significant effect on abdominal immune protection.
- Administering thymalin into the greater omentum eliminated systemic immunodeficiency and local immunodepression in peritonitis patients.
- The route of delivery (intra‑omental vs. intramuscular) appears critical for thymalin’s immune‑modulating effects.
Practical Outcomes
- For most self‑experimenters, the invasive intra‑omental injection isn’t a feasible protocol, so the study offers limited direct guidance. It does suggest that simply taking thymalin by muscle injection may not boost immunity, and any potential benefits likely require targeted delivery methods not easily replicated outside a clinical setting.
Summary
A study on 46 patients with a type of abdominal infection found that injecting the peptide thymalin into the muscle didn’t improve local immune defenses, but delivering it directly into the large omental fat bag cleared both systemic and local immune suppression.
Abstract
Into the complex of treatment of 46 patients with non-circumscribed peritonitis, the thymalin immunocorrector was included. Intramuscular injection had no significant effect on the local factors of immune protection of the abdominal cavity. In thymalin administration into the great omentum, the systemic immunodeficient state and local immunodepression were eliminated.
Study Information
Provider
pubmed
Year
1990